Ilona Krzak a obtenu sa matrise en pharmacie l'universit mdicale de Wrocaw
Sources Tirzepatide Once Weekly for the Treatment of Obesity (June 4, 2022) Tirzepatides Innovative Applications In The Management Of Type 2 Diabetes And Its Future Prospects In Cardiovascular Health (August 28, 2024) MOUNJARO (tirzepatide) Injection, for subcutaneous use (2022) Zepbound (tirzepatide) Injection, for subcutaneous use (2022) Efficacy And Safety Of A Novel Dual Gip And Glp-1 Receptor Agonist Tirzepatide In Patients With Type 2 Diabetes (Surpass-1): A Double-Blind, Randomised, Phase 3 Trial (July 10, 2021) New Drug: Tirzepatide (Mounjaro) (February01, 2023) FDA Approves New Medication for Chronic Weight Management (November 08, 2023)
Application in anti-aging field As age increases, the level of growth hormone in the human body gradually decreases, which can lead to a series of aging related symptoms such as muscle atrophy, fat accumulation, skin laxity, joint pain, etc
By inhibiting prostaglandin E2 (PGE2) synthesis in the hypothalamus which is responsible for raising the thermoregulatory set point during infection or inflammation Ace 125 mg restores the normal set point, promoting peripheral vasodilation and sweating, which dissipates body heat
